U.S. Oil and Gas Stock News

ExlService Holdings (NasdaqGS:EXLS) has received 10 new U.S. patents covering AI and data-focused solutions. The patents span multiple sectors, including insurance, healthcare, retail, utilities, and financial services. Newly protected capabilities target data readiness for AI, workflow automation, and tuning large language models for enterprise use. For shareholders watching NasdaqGS:EXLS, this patent batch lands after a challenging stretch for the stock, with the share price at $30.25 and...

Gen Digital Inc. recently reported third-quarter fiscal 2026 results, with sales rising to US$1,240 million and net income to US$192 million year on year, while also declaring a quarterly dividend of US$0.125 per share payable on March 11, 2026. Alongside these results, the company launched its Gen Agent Trust Hub to address emerging security risks from autonomous AI agents, signaling an effort to position its cyber safety platform at the center of the AI “agentic” ecosystem. We’ll now...

Cohen & Steers plans to convert its Future of Energy Fund into an ETF. The shift aligns the firm with a broader move by traditional asset managers toward ETF structures. The conversion responds to changing investor preferences around access, fees, and trading flexibility. Cohen & Steers, listed as NYSE:CNS, is moving its Future of Energy Fund into an ETF format at a time when investors are paying close attention to listed asset managers and their product line ups. The shares most recently...

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...

How Avantor's FY 2025 Numbers Set the Stage for the Next Chapter Avantor (AVTR) just posted its FY 2025 third quarter results with revenue of US$1,623.8 million, a basic EPS loss of US$1.04 and net income loss of US$711.8 million, putting a sharp spotlight on profitability. The company has seen quarterly revenue move from US$1,714.4 million in Q3 2024 to US$1,686.6 million in Q4 2024, then to US$1,581.4 million and US$1,683.4 million in Q1 and Q2 2025, with EPS shifting from US$0.08 to...

If you are wondering whether Nu Holdings is still good value after its strong run, you are not alone. The stock has quickly become a talking point for many growth focused investors. The share price recently closed at US$17.41, with total returns of 2.3% over the past week, 2.2% over the past month, 2.3% year to date and 27.6% over the last year, while the 3 year return sits at 232.3%. This naturally raises questions about what is already priced in. Recent news flow has centered on Nu...

Federal National Mortgage Association (FNMA) has just posted its FY 2025 third quarter numbers, with revenue of US$7.0b and EPS of US$0.66 setting the tone for the latest update. Over recent quarters, revenue has moved from US$8.0b in FY 2024 Q2 to US$7.4b in Q3 and US$7.8b in Q4, then to US$7.2b in FY 2025 Q1, US$6.5b in Q2 and US$7.0b in Q3. EPS has ranged from US$1.50 in FY 2024 Q2 and US$0.69 in Q3 to close to zero in late 2024 and early 2025, before landing at US$1.19 in FY 2025 Q2 and...

If you are wondering whether Universal's share price reflects what the business is worth, or if the market is overlooking something important, this article is for you. The stock last closed at US$52.87, with returns of a 10% decline over 7 days, a 2.6% decline over 30 days, 0.6% year to date, 4.8% over 1 year, 19.1% over 3 years and 36.7% over 5 years. Recent share price moves have brought Universal back onto investors' radar, especially for those reassessing risk and reward at current...

Latest Earnings Snapshot Tower Semiconductor (NasdaqGS:TSEM) has posted its FY 2025 third quarter numbers with revenue of US$395.7 million and basic EPS of US$0.48, giving investors a clear read on how the year is shaping up. The company has seen revenue move from US$351.2 million in Q2 2024 to US$395.7 million in Q3 2025, while quarterly basic EPS has ranged from US$0.48 to US$0.49 over that period, alongside trailing 12 month revenue of about US$1.5 billion and basic EPS of roughly US$1.75...

Earlier this week, Community Health Accreditation Partner (CHAP) awarded Aveanna Home Health and Hospice a Disease Program Certification for Heart Failure, recognizing compliance with nationally accepted quality metrics and advanced clinician education standards across its Heartways program. This certification highlights Aveanna’s emphasis on specialized, clinically rigorous heart failure care in the home setting, which could strengthen its position with patients, payers, and referral...

Oshkosh Corporation recently reported its fourth-quarter and full-year 2025 results, issued 2026 earnings guidance of approximately US$10.90 diluted EPS, raised its quarterly dividend to US$0.57 per share, and confirmed completion of a long-running share repurchase program totaling about US$1.57 billions since 2015. Taken together, these updates highlight how Oshkosh is balancing reinvestment with increasing cash returns to shareholders, while offering clearer visibility into its expected...

Alexander's Inc. (NYSE:ALX) reported lower quarterly and full year net income and funds from operations. Management highlighted improving New York office occupancy as a key operational development. The CEO pointed to share buybacks as a current priority, reflecting views on the stock's valuation. For investors watching real estate investment trusts, Alexander's sits in an interesting spot. The stock trades at $230.02 and is up 25.6% over the past year and 29.0% over the past three years,...

If you are wondering whether Clear Channel Outdoor Holdings at around US$2.37 is priced attractively or already reflects its prospects, you are in the right place. The stock has recently shown strong momentum, with returns of 10.7% over 7 days, 15.6% over 30 days, 11.8% year to date and 76.9% over the past year, as well as 31.7% over 3 years and 11.3% over 5 years. Recent news around Clear Channel Outdoor Holdings has focused on its position in the out of home advertising market, including...

JD.com (NasdaqGS:JD) has launched JoyExpress, a new last mile delivery service in Europe. JoyExpress is designed to support the rollout of JD.com's European e-commerce platform Joybuy. The service targets same day and next day delivery through a locally based logistics network. For you as an investor, this move puts JD.com more directly in the mix with established European e-commerce and logistics players, rather than keeping its focus mainly on China. JoyExpress ties JD.com's core strength...

If you are wondering whether Weyerhaeuser is offering good value at its current share price, this article will walk you through what the market might be pricing in and what that could mean for you. The stock recently closed at US$27.10, with returns of 1.5% over the last 7 days, 5.2% over 30 days, 13.9% year to date, but a 5.4% decline over 1 year, a 10.0% decline over 3 years and a 3.0% decline over 5 years. These mixed returns set the backdrop for understanding whether the current price...

Event context and recent stock performance Hancock Whitney (HWC) has been drawing fresh attention after its recent share price move, with the stock up about 5% over the past month and about 21% over the past 3 months. See our latest analysis for Hancock Whitney. That recent 30 day share price return of 5.1% and 90 day gain of 21.4% sit alongside a 1 year total shareholder return of 24.6%. This suggests momentum has been building despite some short term pullbacks. If Hancock Whitney’s move has...

How GlobalFoundries' Latest Numbers Set the Stage for the Next Chapter GlobalFoundries (GFS) has just posted its FY 2025 first half results, with revenue of US$3.3 billion and basic EPS of US$0.79, against a backdrop of recent trailing 12 month losses and a current share price of US$48.74. The company has seen revenue move from US$3.2 billion in the first half of 2024 to US$3.3 billion in the first half of 2025, while EPS shifted from US$0.52 to US$0.79 over the same periods. This sets up a...

If you are wondering whether G-III Apparel Group is attractively priced today, you are not alone. This article is here to unpack what the current share price might be telling you about value. The stock last closed at US$30.15, with returns of 0.4% over the past 30 days, 2.2% year to date and an 87.4% gain across 3 years, while the 1 year return sits close to flat at a 0.2% decline. Recent news around G-III Apparel Group has focused on its position in the apparel and consumer durables space...

Inspire Medical Systems has reported its full-year 2025 results, with sales rising to US$911.98 million and net income reaching US$145.42 million, driving basic earnings per share from continuing operations to US$4.95, up from US$1.80 a year earlier. The sharp improvement in profitability and earnings came after analysts had recently turned more cautious on near-term quarterly performance, highlighting a gap between expectations and how efficiently the business converted higher revenue into...

Exelixis (EXEL) has wrapped up FY 2025 with fourth quarter revenue of US$598.7 million and basic EPS of US$0.92, supported by trailing 12 month revenue of about US$2.3 billion and EPS of US$2.88 that sit alongside a higher net profit margin than a year ago. The company has seen quarterly revenue move from US$566.8 million and EPS of US$0.49 in Q4 2024 to US$598.7 million and US$0.92 in Q4 2025, while trailing net profit margin has stepped up from 24% to 33.7%. This sets up a story where...

Aflac reported its fourth-quarter and full-year 2025 results, with revenue of US$4,866 million and net income of US$1,379 million for the quarter, and full-year revenue of US$17.16 billion and net income of US$3.65 billion, both lower than the prior year. Despite these declines, management highlighted strong sales momentum in Japan driven by new cancer and medical products and resilient premium growth in the U.S., suggesting underlying demand for its supplemental insurance offerings remains...